---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-028174"
form_type: "8-K"
ticker: "ARDX"
cik: "0001437402"
company_name: "ARDELYX, INC."
filed_at: "2022-11-03T23:59:59+00:00"
generated_at: "2026-06-22T08:40:21.728375+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ardelyx Q3 2022 net loss $22.9M; IBSRELA sales $4.9M; expects $35M Japan milestone

## Summary
- Net loss of $22.9M ($0.14 per share) versus $43.6M ($0.42) in Q3 2021; narrowed 47%.
- IBSRELA net product sales of $4.9M for Q3 2022, six months into launch.
- Cash, equivalents and investments $90.6M at Sept 30, 2022, down from $116.7M at Dec 31, 2021.
- Kyowa Kirin submitted tenapanor NDA in Japan; Ardelyx expects aggregate $35M milestones in Q4 2022.
- FDA Advisory Committee for XPHOZAH (tenapanor) scheduled for November 16, 2022.

## SEC filing metadata
- accession: 0001628280-22-028174
- form_type: 8-K
- ticker: ARDX
- cik: 0001437402
- company_name: ARDELYX, INC.
- filed_at: 2022-11-03T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1437402/000162828022028174/0001628280-22-028174-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1437402/000162828022028174/ardx-20221103.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-028174
- JSON: https://secwatch.observer/filing/0001628280-22-028174.json
- Plain text: https://secwatch.observer/filing/0001628280-22-028174.txt

## Key facts
- Earnings Releases
  ARDELYX, INC. reported the fiscal quarter ended September 30, 2022 results: net income Net loss for the quarter ended September 30, 2022 was $22.9 million, or $(0.14) per share, EPS $(0.14) per share.
  - Period: the fiscal quarter ended September 30, 2022
  - Net income: Net loss for the quarter ended September 30, 2022 was $22.9 million, or $(0.14) per share
  - EPS: $(0.14) per share
  - Result: reported results
  source text: On November 3, 2022, Ardelyx, Inc. (the “Company”) announced its financial results for the fiscal quarter ended September 30, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1437402/000162828022028174/0001628280-22-028174-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.